- Home
- ALUR vs LUCD Comparison
ALUR vs LUCD Comparison
Compare ALUR & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- LUCD
- Stock Information
- Founded
- ALUR 2009
- LUCD 2018
- Country
- ALUR United States
- LUCD United States
- Employees
- ALUR N/A
- LUCD N/A
- Industry
- ALUR
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALUR
- LUCD Health Care
- Exchange
- ALUR Nasdaq
- LUCD Nasdaq
- Market Cap
- ALUR 22.5M
- LUCD 45.4M
- IPO Year
- ALUR N/A
- LUCD 2021
- Fundamental
- Price
- ALUR $3.14
- LUCD $0.83
- Analyst Decision
- ALUR Strong Buy
- LUCD Strong Buy
- Analyst Count
- ALUR 4
- LUCD 4
- Target Price
- ALUR $75.00
- LUCD $3.63
- AVG Volume (30 Days)
- ALUR 67.5K
- LUCD 358.0K
- Earning Date
- ALUR 11-13-2024
- LUCD 11-13-2024
- Dividend Yield
- ALUR N/A
- LUCD N/A
- EPS Growth
- ALUR N/A
- LUCD N/A
- EPS
- ALUR N/A
- LUCD N/A
- Revenue
- ALUR $34,754,000.00
- LUCD $4,189,000.00
- Revenue This Year
- ALUR N/A
- LUCD $91.72
- Revenue Next Year
- ALUR $2.22
- LUCD $139.38
- P/E Ratio
- ALUR N/A
- LUCD N/A
- Revenue Growth
- ALUR N/A
- LUCD 179.27
- 52 Week Low
- ALUR $2.72
- LUCD $0.63
- 52 Week High
- ALUR $98.75
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- ALUR 26.80
- LUCD 48.29
- Support Level
- ALUR $2.72
- LUCD $0.75
- Resistance Level
- ALUR $9.10
- LUCD $0.87
- Average True Range (ATR)
- ALUR 2.10
- LUCD 0.04
- MACD
- ALUR -0.60
- LUCD 0.01
- Stochastic Oscillator
- ALUR 3.81
- LUCD 47.74
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.